Literature DB >> 6193755

Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.

R Gonggrijp, W J Mullers, C P van Boven.   

Abstract

Ribosomal ribonucleic acid (RNA) and lipopolysaccharide (LPS) from P. aeruginosa were compared with respect to their protective activities in mice against an infection with P. aeruginosa. This study is concentrated on the protective activity of RNA. RNA isolated from purified ribosomes did not contain LPS as determined with the Limulus test. Injection of RNA with the adjuvant dimethyldioctadecylammonium bromide (DDA) protected mice against P. aeruginosa without inducing LPS-specific antibodies. C3H/HeJ mice which are relatively insensitive to the protective activity of LPS could be protected with RNA. The protective activities of RNA and LPS from a mutant strain of P. aeruginosa, PAC 605, containing defective lipopolysaccharide, were compared with the protective activities of RNA and LPS from the parent strain, PAC IR. The protective activity of LPS from PAC 605 was 1000 fold lower than the protective activity of LPS from PAC IR. RNA preparations of both strains induced similar percentages of survival. The protective activity of ribosomal RNA from P. aeruginosa was nonspecific since mice were also protected against a heterologous serotype of P. aeruginosa and against Escherichia coli. RNA from ribosomes of P. aeruginosa, E. coli and the non-lipopolysaccharide containing Saccharomyces cerevisiae had similar protective activities. No protection was obtained with the ribonucleic acid from the E. coli phage MS2. It is concluded that ribosomal RNA has protective activities distinct from those of LPS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193755     DOI: 10.1007/bf00393676

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  15 in total

1.  The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine.

Authors:  J H Lin; L J Berry
Journal:  J Reticuloendothel Soc       Date:  1978-02

2.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

3.  Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides.

Authors:  F G Araujo; J S Remington
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

4.  Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.

Authors:  T K Eisenstein
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

5.  Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

6.  Heterogeneity of the lipopolysaccharide from Pseudomonas aeruginosa.

Authors:  I R Chester; P M Meadow
Journal:  Eur J Biochem       Date:  1975-10-15

7.  The isolation and characterization of lipopolysaccharide-defective mutants of Pseudomonas aeruginosa PAC1.

Authors:  S F Koval; P M Meadow
Journal:  J Gen Microbiol       Date:  1977-02

8.  Analytical characterization of lipopolysaccharide antigens from seven strains of Pseudomonas aeruginosa.

Authors:  D Horton; G Rodemeyer; T H Haskell
Journal:  Carbohydr Res       Date:  1977-05       Impact factor: 2.104

9.  Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.

Authors:  R Gonggrijp; W J Mullers; P J Lemmens; C P van Boven
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

10.  Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides.

Authors:  J Watson; R Riblet
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  3 in total

1.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

2.  Antibacterial resistance, macrophage influx, and activation induced by bacterial rRNA with dimethyldioctadecylammonium bromide.

Authors:  R Gonggrijp; W J Mullers; H F Dullens; C P van Boven
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

3.  RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenes.

Authors:  A C Antonissen; P J Lemmens; R Gonggrijp; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1985       Impact factor: 2.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.